Evidence map›Paper›PMID 21998661›Full record

ArticlePloS one2011

Whole genome sequencing and evolutionary analysis of human respiratory syncytial virus A and B from Milwaukee, WI 1998-2010.

Cecilia Rebuffo-Scheer, Michael Bose, Jie He, Shamim Khaja, Michael Ulatowski, Eric T Beck, Jiang Fan, Swati Kumar, Martha I Nelson, Kelly J Henrickson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Cecilia Rebuffo-ScheerMidwest Respiratory Virus Program, Milwaukee, Wisconsin, United States of America.
Michael Bose
Jie He
Shamim Khaja
Michael Ulatowski
Eric T Beck
Jiang Fan
Swati Kumar
Martha I Nelson
Kelly J Henrickson
Medical College of Wisconsin · USChildren’s Institute · USNational Institutes of Health · US

Funding

Rapid point-of-care diagnostic for bioterrorism "A" agents and Pandemic influenzaU01AI070428 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI HENRICKSON, KELLY J. · 2006 to 2010
$8.5M
Diagnostics for Sepsis and Community-Acquired PneumoniaU01AI066584 · NIAID · NEXOGEN, INC. · PI MATHER, PH.D., ELIZABETH L · 2005 to 2009
$2.4M
Multipled POC device for antigen/molecular detection of influenza & other virusesU01AI077988 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI HENRICKSON, KELLY J. · 2008 to 2011
$1.9M
NIAID NIH HHS U01 AI066584NIAID NIH HHS U01-AI-066584NIAID NIH HHS U01 AI070428NIAID NIH HHS U01-AI-070428NIAID NIH HHS U01 AI077988NIAID NIH HHS U01-AI-077988
6 · The paper itself

Abstract

backgroundRespiratory Syncytial Virus (RSV) is the leading cause of lower respiratory-tract infections in infants and young children worldwide. Despite this, only six complete genome sequences of original strains have been previously published, the most recent of which dates back 35 and 26 years for RSV group A and group B respectively. METHODOLOGY/PRINCIPAL

findingsWe present a semi-automated sequencing method allowing for the sequencing of four RSV whole genomes simultaneously. We were able to sequence the complete coding sequences of 13 RSV A and 4 RSV B strains from Milwaukee collected from 1998-2010. Another 12 RSV A and 5 RSV B strains sequenced in this study cover the majority of the genome. All RSV A and RSV B sequences were analyzed by neighbor-joining, maximum parsimony and Bayesian phylogeny methods. Genetic diversity was high among RSV A viruses in Milwaukee including the circulation of multiple genotypes (GA1, GA2, GA5, GA7) with GA2 persisting throughout the 13 years of the study. However, RSV B genomes showed little variation with all belonging to the BA genotype. For RSV A, the same evolutionary patterns and clades were seen consistently across the whole genome including all intergenic, coding, and non-coding regions sequences. CONCLUSIONS/SIGNIFICANCE: The sequencing strategy presented in this work allows for RSV A and B genomes to be sequenced simultaneously in two working days and with a low cost. We have significantly increased the amount of genomic data that is available for both RSV A and B, providing the basic molecular characteristics of RSV strains circulating in Milwaukee over the last 13 years. This information can be used for comparative analysis with strains circulating in other communities around the world which should also help with the development of new strategies for control of RSV, specifically vaccine development and improvement of RSV diagnostics.

Indexed as

Evolution, MolecularCell LineCodon, InitiatorCodon, TerminatorDNA, IntergenicGenome, ViralGenotypeGlycoproteinsHumansINDEL MutationPhylogenyRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsSequence AnalysisTime FactorsViral VaccinesCodon, InitiatorCodon, TerminatorDNA, IntergenicGlycoproteinsViral Vaccines

Identifiers

PMID21998661
PMCPMC3188560
OpenAlexW1970650250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.